- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1860-2002
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Quantification of Tau Load Using [18F]AV1451 PET ; day:3 ; month:4 ; year:2017 ; pages:1-9
Molecular imaging & biology ; (3.4.2017), 1-9
- Schlagwort
-
Nichtmedikamentöse Therapie
- Urheber
-
Golla, Sandeep S. V.
- Beteiligte Personen und Organisationen
-
Timmers, Tessa
Ossenkoppele, Rik
Groot, Colin
Verfaillie, Sander
Scheltens, Philip
Flier, Wiesje M. van der
Schwarte, Lothar
Mintun, Mark A.
Devous, Michael
Schuit, Robert C.
Windhorst, Albert D.
Lammertsma, Adriaan A.
Boellaard, Ronald
Berckel, Bart N. M. van
Yaqub, Maqsood
SpringerLink (Online service)
- DOI
-
10.1007/s11307-017-1080-z
- URN
-
urn:nbn:de:1111-201704212394
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Golla, Sandeep S. V.
- Timmers, Tessa
- Ossenkoppele, Rik
- Groot, Colin
- Verfaillie, Sander
- Scheltens, Philip
- Flier, Wiesje M. van der
- Schwarte, Lothar
- Mintun, Mark A.
- Devous, Michael
- Schuit, Robert C.
- Windhorst, Albert D.
- Lammertsma, Adriaan A.
- Boellaard, Ronald
- Berckel, Bart N. M. van
- Yaqub, Maqsood
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum](/assets/placeholder/searchResultMediaUnknown.png)
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [18F]Flortaucipir and [18F]Florbetapir Brain PET Studies
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease
A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus
Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease
A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [18F]Flortaucipir and [18F]Florbetapir Brain PET Studies
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease
A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus
Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease
A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [18F]Flortaucipir and [18F]Florbetapir Brain PET Studies
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease
A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus
Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease
A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial